RE:looking for a stock in MJOwners pump the tires of shareholders here. I was in briefly an realized what was going on (not going on) here. Lots of hopefuls for a BC genetics deal, but I don't see it amounting to much other than a spike and drop. I'm an honest investor/critic. If you want a good short MJ play, CANN or MMJ who will both be licensed by end of March. If you're in for a longer hold, LIB is a beauty, or LG has unreal potential... SP plagued by bad timing (very red days) for their good news. LIB has MMAR license and 2 pending late stage apps which will both come in before July. One of which is distribution. Well diversified. LG has investments in LP in Australia, huge potential with House of Hemp (1.2M sqft I believe) in Dubr trade port where they want to grow cannabis, and also facility in Canada to be complete in Q4 of 2018. At this point, stay clear of the sub-.40 pot plays. They are too far behind at this point. All 4 of the above listed are $1+ in 2018. The longer plays listed have potential to be $5 stocks by 2019. Done lots of DD. LIB has lowest float of the bunch with distribution, LP, blockchain, and CBD pet products currently testing (underrated billion dollar industry). I know I'll get rated 1 star on this post from the board, but I don't care. Honesty is worth more than my irrelevant stockhouse rating. 1-trick ponies aren't the ones to bet on at this point. Small fish will fry. My opinion, but I've followed the sector for over a year now. MYM made me a ton of cash. These 4 will too. I really like MPX for current dispensary income ($14M I'm 2017) and 60,000sqft facility in Canada but sold out due to uncertainty of CSE listings with US holdings. I don't want any potential of delisting. Well over 100,000 shares combined in the 4 recommended. Do what you want, these are my opinions. But too many people believe everything favourable that they read. I'm the guy who will tell it like it is.